Giacometti’s Pointing Man.Giacometti’s Pointing Man.

A 1947 Giacometti sculpture is poised to set a record next month when it hits the auction block for the first time ever and is expected to sell for €120 million, Christie’s said.

The 180-cm bronze, Pointing Man, is one of only a handful of art works to command a presale estimate in excess of €90 million.

The record price for a sculpture sold at auction is €96 million paid for Giacometti’s L’Homme qui marche I in 2010.

“Pointing Man is unquestionably Giacometti’s greatest sculpture,” said Jussi Pylkkanen, Christie’s global president. “This example stands apart from all others because it is unique. It was hand-painted by the artist himself.”

Giacometti was born in Switzerland in 1901 and died in 1966.

The sculpture, executed in Giacometti’s trademark elongated style with a rippling, irregular and scarred surface, is one of six casts.

Four of them grace major museums, including London’s Tate and New York’s Museum of Modern Art. The work has been in the same private collection, which Christie’s did not identify, since 1970.

Pointing Man is the second piece of art from New York’s key spring sales which has a presale estimate of more than €90 million.

Last month the. auction house announced it would sell Picasso’s vibrant cubist work, Les femmes d’Alger (Version ‘O’), with an estimate of €130 million.

Both works will be offered at Christie’s’ May 11 sale, ‘Looking Forward to the Past,’ comprised of a mix of important works from various periods, which augments its semi-annual auctions of impressionist/ modern and contemporary art.

Two Giacomettis are the only sculptures that have broken the €90 million barrier at auction.

The most expensive work ever sold at auction, Francis Bacon’s triptych Three Studies of Lucian Freud, fetched €130 million in November 2013, although several works have sold for more on the private market.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.